SCHEDULE 13D/A//SEC Filing
Revance Therapeutics, Inc. SCHEDULE 13D/A
Accession 0000950103-25-000171
CIK 0001992112other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 9:00 AM ET
Size
41.3 KB
Accession
0000950103-25-000171
Issuer
Teoxane SA
CIK 0001992112
Entity typeother
IncorporatedSwitzerland
Related Parties
1- filerCIK 0001992112
Filing Metadata
- Form type
- SCHEDULE 13D/A
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 9:00 AM ET
- Size
- 41.3 KB